Witnessing the stock’s movement on the chart, on July 23, 2021, Calithera Biosciences Inc. (NASDAQ: CALA) had a quiet start as it plunged -0.96% to $2.06. During the day, the stock rose to $2.085 and sunk to $2.00 before settling in for the price of $2.08 at the close. Taking a more long-term approach, CALA posted a 52-week range of $1.78-$6.18.
Meanwhile, its Annual Earning per share during the time was 6.30%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 31.00%. This publicly-traded company’s shares outstanding now amounts to $72.25 million, simultaneously with a float of $63.79 million. The organization now has a market capitalization sitting at $154.01 million. At the time of writing, stock’s 50-day Moving Average stood at $2.13, while the 200-day Moving Average is $3.07.
Calithera Biosciences Inc. (CALA) Ownership Facts and Figures
Nothing is more important than checking the behaviour of major investors towards the stock of the Biotechnology industry. Calithera Biosciences Inc.’s current insider ownership accounts for 0.71%, in contrast to 75.00% institutional ownership. According to the most recent insider trade that took place on Dec 16, this organization’s Chief Medical Officer sold 2,447 shares at the rate of 6.00, making the entire transaction reach 14,682 in total value, affecting insider ownership by 11,094.
Calithera Biosciences Inc. (CALA) Earnings and Revenue Records
As on 3/30/2021, Multinational firm has announced its last quarter scores, in which it reported -$0.28 earnings per share (EPS) for the period topping the consensus outlook (set at -$0.28) by $0. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.23 per share during the current fiscal year.
Calithera Biosciences Inc.’s EPS increase for this current 12-month fiscal period is 31.00% and is forecasted to reach -0.87 in the upcoming year.
Calithera Biosciences Inc. (NASDAQ: CALA) Trading Performance Indicators
Let’s observe the current performance indicators for Calithera Biosciences Inc. (CALA). It’s Quick Ratio in the last reported quarter now stands at 7.70. The Stock has managed to achieve an average true range (ATR) of 0.11.
In the same vein, CALA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -1.22, a figure that is expected to reach -0.24 in the next quarter, and analysts are predicting that it will be -0.87 at the market close of one year from today.
Technical Analysis of Calithera Biosciences Inc. (CALA)
Going through the that latest performance of [Calithera Biosciences Inc., CALA]. Its last 5-days volume of 0.54 million was inferior to the volume of 1.29 million it revealed a year ago. During the previous 9 days, stock’s Stochastic %D was recorded 81.98% While, its Average True Range was 0.11.
Raw Stochastic average of Calithera Biosciences Inc. (CALA) in the period of the previous 100 days is set at 23.53%, which indicates a major fall in contrast to 75.68% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 61.20% that was higher than 49.88% volatility it exhibited in the past 100-days period.